Description
ROSUPRL CP Tablet 10’s, a potent pharmaceutical solution, contains the active ingredient Rivaroxaban, a direct factor Xa inhibitor. Indicated for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), as well as for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). This oral medication is available in a strength of 20mg and is essential for anticoagulation therapy in high-risk patients. ROSUPRL CP Tablet 10’s plays a crucial role in reducing the risk of blood clots, thereby improving patient outcomes.
Reviews
There are no reviews yet.